These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 19941944

  • 1. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
    Mourão SC, da Silva C, Bresolin TM, Serra CH, Porta V.
    Int J Pharm; 2010 Feb 15; 386(1-2):201-7. PubMed ID: 19941944
    [Abstract] [Full Text] [Related]

  • 2. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
    Bertocchi P, Antoniella E, Valvo L, Alimonti S, Memoli A.
    J Pharm Biomed Anal; 2005 Apr 01; 37(4):679-85. PubMed ID: 15797788
    [Abstract] [Full Text] [Related]

  • 3. The influence of process variables of preparation of oxycellulose beads on their dissolution profile.
    Bajerová M, Muselík J, Gajdziok J, Masteiková R, Dvorácková K.
    Acta Pol Pharm; 2013 Apr 01; 70(2):271-81. PubMed ID: 23614283
    [Abstract] [Full Text] [Related]

  • 4. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK, Kołodziejska J, Zgoda MM.
    Polim Med; 2012 Apr 01; 42(2):121-32. PubMed ID: 23016443
    [Abstract] [Full Text] [Related]

  • 5. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM, Abdel-Rahman AA, Ahmed SM, Alanazi FK, Habib WA, Sakr A.
    Acta Pol Pharm; 2016 Apr 01; 73(2):439-52. PubMed ID: 27180437
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH, Tazeen J, Merchant HA, Yousuf RI.
    Pak J Pharm Sci; 2006 Apr 01; 19(2):119-24. PubMed ID: 16751122
    [Abstract] [Full Text] [Related]

  • 7. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A, Ozkan Y, Işimer A.
    Farmaco; 2005 Feb 01; 60(2):171-7. PubMed ID: 15752476
    [Abstract] [Full Text] [Related]

  • 8. Influence of ethanol on aspirin release from hypromellose matrices.
    Roberts M, Cespi M, Ford JL, Dyas AM, Downing J, Martini LG, Crowley PJ.
    Int J Pharm; 2007 Mar 06; 332(1-2):31-7. PubMed ID: 17084050
    [Abstract] [Full Text] [Related]

  • 9. Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests.
    van der Weerd J, Kazarian SG.
    J Pharm Sci; 2005 Sep 06; 94(9):2096-109. PubMed ID: 16052556
    [Abstract] [Full Text] [Related]

  • 10. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G, Wedemeyer RS, Nagel S, Giessmann T, Mönnikes H, Wilson CG, Siegmund W, Weitschies W.
    Eur J Pharm Biopharm; 2008 Oct 06; 70(2):421-8. PubMed ID: 18582568
    [Abstract] [Full Text] [Related]

  • 11. Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN).
    Ivic B, Ibric S, Betz G, Zorica D.
    Arch Pharm Res; 2010 Jan 06; 33(1):103-13. PubMed ID: 20191351
    [Abstract] [Full Text] [Related]

  • 12. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
    Abdullah MD, Bepary S, Rouf AS.
    Pak J Pharm Sci; 2008 Jan 06; 21(1):70-7. PubMed ID: 18166523
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T, Kanbe H, Okada M, Kawase I, Ikeda Y, Onuki Y, Kaneko T, Sonobe T.
    Int J Pharm; 2007 Aug 16; 341(1-2):105-13. PubMed ID: 17512147
    [Abstract] [Full Text] [Related]

  • 14. Study of dissolution hydrodynamic conditions versus drug release from hypromellose matrices: the influence of agitation sequence.
    Asare-Addo K, Levina M, Rajabi-Siahboomi AR, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2010 Dec 01; 81(2):452-60. PubMed ID: 20729043
    [Abstract] [Full Text] [Related]

  • 15. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
    Avachat A, Kotwal V.
    AAPS PharmSciTech; 2007 Oct 19; 8(4):E88. PubMed ID: 18181548
    [Abstract] [Full Text] [Related]

  • 16. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K, Rabisková M, Masteiková R, Muselík J, Krejcová K.
    Drug Dev Ind Pharm; 2009 Aug 19; 35(8):930-40. PubMed ID: 19274510
    [Abstract] [Full Text] [Related]

  • 17. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME, Zornoza A, Goñi Mdel M, Isasi JR, Vélaz I, Martín C, Sánchez M, Martínez-Ohárriz MC.
    Drug Dev Ind Pharm; 2009 Oct 19; 35(10):1264-70. PubMed ID: 19555243
    [Abstract] [Full Text] [Related]

  • 18. Individual and interacting effects of formulation variables on the tensile strength and microbial survival in diclofenac tablets.
    Ayorinde JO, Itiola OA.
    Arch Pharm Res; 2010 Mar 19; 33(3):395-403. PubMed ID: 20361304
    [Abstract] [Full Text] [Related]

  • 19. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z, Fassihi R.
    AAPS PharmSciTech; 2017 Feb 19; 18(2):462-472. PubMed ID: 27106916
    [Abstract] [Full Text] [Related]

  • 20. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA, Al-Hanbali OA, Kanaan RA, Shakya AK, Maraqa A.
    Acta Pol Pharm; 2010 Feb 19; 67(1):93-7. PubMed ID: 20210085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.